 preliminari report ticarcillin clavulan versu tripl antibiot therapi children ruptur append standard therapi childhood append combin antibiot therapi ampicillin gentamicin clindamycin schedul possibl aminoglycosid toxic altern desir altern timentin combin agent ticarcillin disodium potassium agent conveni dose schedul standard therapi possibl aminoglycosid ototox nephrotox activ vitro pathogen ruptur append children preliminari result ongo prospect open label trial ticarcillin clavulan ampicillin gentamicin clindamycin childhood append herein evalu necessari singl agent therapi ticarcillin clavulan equival safeti efficaci combin therapi rel merit immedi versu primari closur abdomin wound appendectomi